The S&P 500’s tech giants will compete for attention as they barrage the marketplace with third-quarter revenues in the week prior to the Nov. 3 election. See full story.
Ready for another Huge Tech hearing/earnings doubleheader?
3 months earlier, Huge Tech’s greatest names traipsed into a Congressional hearing to be scolded by political leaders for their organization supremacy, then paraded in front of Wall Street a day later on to be cheered for their monetary supremacy. Someone needs to have delighted in that, since it will take place all over once again. See full story.
Trump, Biden argument pitches stop working to make mark with these Pennsylvania citizens
Regardless of a more civil and frequently substantive conversation of essential concerns for citizens in the Keystone State than in the very first governmental argument previously this month, citizens here informed MarketWatch that the case did little to alter their minds, simply 12 days from Election Day. See full story.
Markets are driving shift to green energy far from oil and gas reliance despite election winner– the distinction is how quick
The U.S. will shift to a clean-energy mix despite who wins the White Home. However the speed of that modification, and with it, the toll on the environment, might look drastically various depending upon the election result. See full story.
The very first FDA-approved coronavirus treatment is here. Who gets it and when
Remdesivir, now called Veklury, is the very first coronavirus treatment to get complete approval from the Fda. See full story.
‘ My mother-in-law has dementia and counts on her partner as a caretaker. We can not count on her assistance in this matter at all.’ See full story.